|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3142751 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15722195.3 |
| Date of filing the European patent application | 2015-05-12 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation | 2019-09-25 |
| (86) | Number | PCT/EP2015/060523 |
| Date | 2015-05-12 |
| (87) | Number | WO 2015/173267 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201461992658 P | 2014-05-13 | US | |
| 201562105992 P | 2015-01-21 | US | |
| 201562114336 P | 2015-02-10 | US |
| (72) |
NARWAL, Rajesh, US
ROBBINS, Paul, US
KARAKUNNEL, Joyson, US
DAR, Mohammed M., US
|
| (73) |
MedImmune Limited,
Milstein Building Granta Park, Cambridge Cambridgeshire CB21 6GH,
GB
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Anti-B7-H1 ir anti-CTLA-4 antikūnai nesmulkialąstelinio plaučių vėžio gydymui |
| ANTI-B7-H1 AND ANTI-CTLA-4 ANTIBODIES FOR TREATING NON-SMALL CELL LUNG CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 11 | 289.00 EUR |
| 2026-05-12 |